Assignee
ARIUS RES INC
CA·33 granted patents·17 pending applications·484 citations·filing 1999–2008
Top patents by PatentIndex Score
50 records- 0197US6180357B1Individualized patient-specific anti-cancer antibodiesARIUS RES INC·Filed 1999·Granted Jan 30, 2001·173 cites·1 claims
- 0296US7420040B2Cytotoxicity mediation of cells evidencing surface expression of TROP-2ARIUS RES INC·Filed 2007·Granted Sep 2, 2008·65 cites·9 claims
- 0395US7420041B2Cytotoxicity mediation of cells evidencing surface expression of TROP-2ARIUS RES INC·Filed 2007·Granted Sep 2, 2008·59 cites·9 claims
- 0495US6657048B2Individualized anti-cancer antibodiesARIUS RES INC·Filed 2000·Granted Dec 2, 2003·56 cites·2 claims
- 0594US7189825B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2004·Granted Mar 13, 2007·24 cites·16 claims
- 0692US7456016B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2007·Granted Nov 25, 2008·11 cites·8 claims
- 0791US7009040B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2003·Granted Mar 7, 2006·16 cites·16 claims
- 0889US7431923B2Cytotoxicity mediation of cells evidencing surface expression of CD63ARIUS RES INC·Filed 2005·Granted Oct 7, 2008·7 cites·6 claims
- 0984US7442777B2Cytotoxicity mediation of cells evidencing surface expression of CD63ARIUS RES INC·Filed 2006·Granted Oct 28, 2008·6 cites·5 claims
- 1084US7393531B2Cytotoxicity mediation of cells evidencing surface expression of MCSPARIUS RES INC·Filed 2004·Granted Jul 1, 2008·11 cites·10 claims
- 1184US6794494B1Cancerous disease modifying antibodiesARIUS RES INC·Filed 2003·Granted Sep 21, 2004·17 cites·10 claims
- 1283US7252821B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2003·Granted Aug 7, 2007·9 cites·13 claims
- 1382US7411046B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2006·Granted Aug 12, 2008·5 cites·20 claims
- 1482US7189397B2Cytotoxicity mediation of cells evidencing surface expression of CD44ARIUS RES INC·Filed 2003·Granted Mar 13, 2007·11 cites·16 claims
- 1580US7468254B2Cytotoxicity mediation of cells evidencing surface expression of MCSPARIUS RES INC·Filed 2004·Granted Dec 23, 2008·5 cites·4 claims
- 1680US7399835B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2005·Granted Jul 15, 2008·4 cites·17 claims
- 1776US7361342B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2004·Granted Apr 22, 2008·3 cites·5 claims
- 1872US7175846B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2006·Granted Feb 13, 2007·1 cites·8 claims
- 1970US7186808B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2004·Granted Mar 6, 2007·0 cites·16 claims
- 2069US2009074662A1Cancerous Disease modifying antibodiesARIUS RES INC·Filed 2008·Application pending·0 cites
- 2168US7485300B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2007·Granted Feb 3, 2009·0 cites·36 claims
- 2267US2008267864A1Cancerous disease modifying antibodiesARIUS RES INC·Filed 2008·Application pending·0 cites
- 2364US7456258B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2006·Granted Nov 25, 2008·0 cites·20 claims
- 2464US7452978B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2006·Granted Nov 18, 2008·0 cites·20 claims
- 2563US2009142263A1Cytotoxicity mediation of cells evidencing surface expression of TROP-2ARIUS RES INC·Filed 2008·Application pending·0 cites
- 2663US2009191118A1Cytotoxicity mediation of cells evidencing surface expression of TROP-2ARIUS RES INC·Filed 2008·Application pending·0 cites
- 2761US7361343B2Cytotoxicity mediation of cells evidencing surface expression of CD63ARIUS RES INC·Filed 2004·Granted Apr 22, 2008·1 cites·10 claims
- 2860US2009068182A1Cytotoxicity mediation of cells evidencing surface expression of CD9ARIUS RES INC·Filed 2008·Application pending·0 cites
- 2959US2008213169A1Cytotoxicity mediation of cells evidencing surface expression of CD59ARIUS RES INC·Filed 2007·Application pending·0 cites
- 3058US2004141979A1Cancerous disease modifying antibodiesARIUS RES INC·Filed 2003·Application pending·0 cites
- 3157US7247476B2Individualized anti-cancer antibodiesARIUS RES INC·Filed 2005·Granted Jul 24, 2007·0 cites·6 claims
- 3257US2009022722A1Cytotoxicity mediation of cells evidencing surface expression of CD59ARIUS RES INC·Filed 2008·Application pending·0 cites
- 3356US7420039B2Individualized anti-cancer antibodiesARIUS RES INC·Filed 2006·Granted Sep 2, 2008·0 cites·7 claims
- 3456US7348413B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2005·Granted Mar 25, 2008·0 cites·17 claims
- 3556US2008089891A1Cancerous disease modifying antibodiesARIUS RES INC·Filed 2007·Application pending·0 cites
- 3656US2005255041A1Cancerous disease modifying antibodiesARIUS RES INC·Filed 2004·Application pending·0 cites
- 3754US7456259B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2006·Granted Nov 25, 2008·0 cites·20 claims
- 3854US7452979B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2006·Granted Nov 18, 2008·0 cites·20 claims
- 3954US7195764B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2004·Granted Mar 27, 2007·0 cites·7 claims
- 4053US7256272B2Individualized anti-cancer antibodiesARIUS RES INC·Filed 2003·Granted Aug 14, 2007·0 cites·6 claims
- 4151US7256271B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2003·Granted Aug 14, 2007·0 cites·3 claims
- 4251US2006140963A1Cytotoxicity mediation of cells evidencing surface expression of CD59ARIUS RES INC·Filed 2006·Application pending·0 cites
- 4350US2010166652A1Laminin receptor 1 precursor protein (37LRP) epitope delineated by an hepatocellular carcinoma specific antibodyARIUS RES INC·Filed 2008·Application pending·0 cites
- 4448US2008124327A1Cytotoxicity mediation of cells evidencing surface expression of CD44ARIUS RES INC·Filed 2007·Application pending·0 cites
- 4547US7488475B2Antibody therapy of tumorsARIUS RES INC·Filed 2006·Granted Feb 10, 2009·0 cites·5 claims
- 4647US2008131429A1Cytotoxicity mediation of cells evidencing surface expression of CD44ARIUS RES INC·Filed 2007·Application pending·0 cites
- 4747US2008213267A1Cytotoxicity mediation of cells evidencing surface expression of TROP-2ARIUS RES INC·Filed 2007·Application pending·0 cites
- 4846US7419792B2Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibodyARIUS RES INC·Filed 2005·Granted Sep 2, 2008·0 cites·9 claims
- 4946US2008025977A1Cytotoxicity mediation of cells evidencing surface expression of CD59ARIUS RES INC·Filed 2007·Application pending·0 cites
- 5045US2008131428A1Cytotoxicity mediation of cells evidencing surface expression of TROP-2ARIUS RES INC·Filed 2007·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →